Cargando…
Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda
Background: High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda. Methods: Between July 2018 and March 2021, HIV sero-nega...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180097/ https://www.ncbi.nlm.nih.gov/pubmed/35681962 http://dx.doi.org/10.3390/ijerph19116377 |
_version_ | 1784723433043525632 |
---|---|
author | Kabarambi, Anita Kansiime, Sheila Kusemererwa, Sylvia Kitonsa, Jonathan Kaleebu, Pontiano Ruzagira, Eugene |
author_facet | Kabarambi, Anita Kansiime, Sheila Kusemererwa, Sylvia Kitonsa, Jonathan Kaleebu, Pontiano Ruzagira, Eugene |
author_sort | Kabarambi, Anita |
collection | PubMed |
description | Background: High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda. Methods: Between July 2018 and March 2021, HIV sero-negative adults (18–45 years) at high risk of HIV infection were identified through HIV counselling and testing (HCT) from sex-work hotspots along the trans-African highway and fishing communities along the shores of Lake Victoria. Study procedures included collection of baseline socio-demographic data, quarterly HCT, and 6-monthly collection of sexual risk behaviour data. Retention strategies included collection of detailed locator data, short clinic visits (1–2 h), flexible reimbursement for transport costs, immediate (≤7 days) follow-up of missed visits via phone and/or home visits, and community engagement meetings. LTFU was defined as missing ≥2 sequential study visits. Poisson regression models were used to identify baseline factors associated with LTFU. Results: 672 participants were included in this analysis. Of these, 336 (50%) were female and 390 (58%) were ≤24 years. The median follow-up time was 11 months (range: 0–31 months). A total 214 (32%) participants were LTFU over 607.8 person-years of observation (PYO), a rate of 35.2/100 PYO. LTFU was higher in younger participants (18–24 years versus 35–45 years, adjusted rate ratio (aRR) = 1.29, 95% confidence interval (CI) 0.80–2.11), although this difference was not significant. Female sex (aRR = 2.07, 95% CI, 1.51–2.84), and recreational drug use (aRR = 1.61, 95% CI, 1.12–2.34) were significantly associated with increased LTFU. Engagement in transactional sex was associated with increased LTFU (aRR = 1.36, 95% CI, 0.97–1.90) but this difference was not significant. LTFU was higher in 2020–2021 (the period of COVID-19 restrictions) compared to 2018–2019 (aRR = 1.54, 1.17–2.03). Being Muslim or other (aRR = 0.68, 95% CI 0.47–0.97) and self-identification as a sex worker (aRR = 0.47, 95% CI, 0.31–0.72) were associated with reduced LTFU. Conclusion: We observed a high LTFU rate in this cohort. LTFU was highest among women, younger persons, recreational drug users, and persons who engage in transactional sex. Efforts to design retention strategies should focus on these subpopulations. |
format | Online Article Text |
id | pubmed-9180097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91800972022-06-10 Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda Kabarambi, Anita Kansiime, Sheila Kusemererwa, Sylvia Kitonsa, Jonathan Kaleebu, Pontiano Ruzagira, Eugene Int J Environ Res Public Health Review Background: High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda. Methods: Between July 2018 and March 2021, HIV sero-negative adults (18–45 years) at high risk of HIV infection were identified through HIV counselling and testing (HCT) from sex-work hotspots along the trans-African highway and fishing communities along the shores of Lake Victoria. Study procedures included collection of baseline socio-demographic data, quarterly HCT, and 6-monthly collection of sexual risk behaviour data. Retention strategies included collection of detailed locator data, short clinic visits (1–2 h), flexible reimbursement for transport costs, immediate (≤7 days) follow-up of missed visits via phone and/or home visits, and community engagement meetings. LTFU was defined as missing ≥2 sequential study visits. Poisson regression models were used to identify baseline factors associated with LTFU. Results: 672 participants were included in this analysis. Of these, 336 (50%) were female and 390 (58%) were ≤24 years. The median follow-up time was 11 months (range: 0–31 months). A total 214 (32%) participants were LTFU over 607.8 person-years of observation (PYO), a rate of 35.2/100 PYO. LTFU was higher in younger participants (18–24 years versus 35–45 years, adjusted rate ratio (aRR) = 1.29, 95% confidence interval (CI) 0.80–2.11), although this difference was not significant. Female sex (aRR = 2.07, 95% CI, 1.51–2.84), and recreational drug use (aRR = 1.61, 95% CI, 1.12–2.34) were significantly associated with increased LTFU. Engagement in transactional sex was associated with increased LTFU (aRR = 1.36, 95% CI, 0.97–1.90) but this difference was not significant. LTFU was higher in 2020–2021 (the period of COVID-19 restrictions) compared to 2018–2019 (aRR = 1.54, 1.17–2.03). Being Muslim or other (aRR = 0.68, 95% CI 0.47–0.97) and self-identification as a sex worker (aRR = 0.47, 95% CI, 0.31–0.72) were associated with reduced LTFU. Conclusion: We observed a high LTFU rate in this cohort. LTFU was highest among women, younger persons, recreational drug users, and persons who engage in transactional sex. Efforts to design retention strategies should focus on these subpopulations. MDPI 2022-05-24 /pmc/articles/PMC9180097/ /pubmed/35681962 http://dx.doi.org/10.3390/ijerph19116377 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kabarambi, Anita Kansiime, Sheila Kusemererwa, Sylvia Kitonsa, Jonathan Kaleebu, Pontiano Ruzagira, Eugene Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda |
title | Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda |
title_full | Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda |
title_fullStr | Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda |
title_full_unstemmed | Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda |
title_short | Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda |
title_sort | predictors of loss to follow-up in an hiv vaccine preparedness study in masaka, uganda |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180097/ https://www.ncbi.nlm.nih.gov/pubmed/35681962 http://dx.doi.org/10.3390/ijerph19116377 |
work_keys_str_mv | AT kabarambianita predictorsoflosstofollowupinanhivvaccinepreparednessstudyinmasakauganda AT kansiimesheila predictorsoflosstofollowupinanhivvaccinepreparednessstudyinmasakauganda AT kusemererwasylvia predictorsoflosstofollowupinanhivvaccinepreparednessstudyinmasakauganda AT kitonsajonathan predictorsoflosstofollowupinanhivvaccinepreparednessstudyinmasakauganda AT kaleebupontiano predictorsoflosstofollowupinanhivvaccinepreparednessstudyinmasakauganda AT ruzagiraeugene predictorsoflosstofollowupinanhivvaccinepreparednessstudyinmasakauganda |